Abbott Labs to Sell 20.5 Million COVID-19 Antigen Tests to Canadian Government

Abbott Laboratories (NYSE:ABT) has signed a deal with the government of Canada to potentially supply around 21 million of its Panbio COVID-19 tests, the latter announced on Tuesday. The move closely follows the approval of the test by Health Canada, the nation's healthcare industry regulator.